Canada's Race to End Cervical Cancer: A 2040 Goal in Jeopardy

TORONTO, ON – January 22, 2026 – Canada stands at a critical crossroads in its ambitious mission to eliminate cervical cancer by 2040. Despite being almost entirely preventable, the disease claimed approximately 430 lives in 2025, and new data reveals a troubling trend: cervical cancer is now the fastest-increasing cancer in the country, with incidence rates rising 3.7% annually since 2015. This marks the first significant increase since 1984, sounding an alarm for public health officials.

During Cervical Cancer Awareness Month, the Canadian Partnership Against Cancer (the Partnership) is reinforcing the urgency of its national strategy, highlighting that while the 2040 goal remains achievable, progress has dangerously plateaued. The path forward, outlined in the Action Plan for the Elimination of Cervical Cancer in Canada, 2020-2030, depends on an aggressive two-pronged approach: boosting human papillomavirus (HPV) vaccination rates and revolutionizing screening by shifting from the traditional Pap test to more effective HPV-based testing.

"The goal of eliminating cervical cancer is still within reach," says Dr. Craig Earle, CEO of the Partnership. "But we will only achieve it by focusing on populations that face the greatest barriers to HPV screening and vaccination."

The Vaccination Gap

A cornerstone of the elimination strategy is achieving a 90% HPV vaccination rate for adolescents by 2025. However, Canada is falling significantly short of this crucial target. Current national estimates place the HPV vaccination completion rate at just 64%, a figure that masks stark regional disparities.

Provincial and territorial data reveals a patchwork of progress. While Newfoundland and Labrador has reported a laudable 92.4% uptake for 17-year-olds, other provinces lag considerably. Ontario's rate for 14-year-olds in the 2023-24 school year was 68.0%. Overall, only one province has successfully surpassed the 90% threshold needed to accelerate elimination.

In an effort to close this gap, some jurisdictions, including Quebec, Yukon, Nova Scotia, and British Columbia, have adopted a publicly funded one-dose HPV vaccination schedule. This policy change is intended to simplify logistics and potentially expand eligibility to catch up historically under-immunized groups. The challenge extends to adults as well, with overall HPV immunization coverage for those 18 and older sitting at a mere 17.7% in 2023, highlighting a significant missed opportunity for prevention beyond school-based programs.

A Revolution in Screening

The second pillar of Canada’s strategy involves a fundamental shift in how cervical cancer is detected. The Action Plan calls for replacing the long-standing Pap test with HPV primary screening, a more sensitive method that detects the virus itself, often before cellular changes occur. Recent modelling indicates that making this advanced screening available across all provinces and territories by 2035 is essential to meeting the 2040 elimination target.

Despite the test's proven superiority, implementation across the country has been sluggish. As of early 2026, most provinces are still in the planning or pilot stages. British Columbia stands out as a national leader, having launched a comprehensive cervical cancer self-screening program in January 2024. The program, which allows individuals to order a kit and collect a sample themselves, has been met with overwhelming demand, with over 30,000 kits distributed in its first year.

Other regions are following suit. Prince Edward Island is moving towards a clinical rollout after a successful pilot, and the Northwest Territories is set to launch the first organized screening program in the territories using HPV self-screening. Quebec has also begun a phased deployment of HPV testing. Yet, national screening participation has declined from 74% in 2017 to 69% in 2024, underscoring the need to accelerate these new, more accessible options.

"Actions like implementing HPV self-screening in cervical cancer screening programs must be at the forefront," Dr. Earle emphasizes.

Health Equity at the Core of the Mission

Central to the entire elimination effort is the principle of health equity. The Action Plan explicitly recognizes that success is impossible without dismantling the systemic barriers faced by underserved communities. Historically, First Nations, Inuit, and Métis peoples have suffered disproportionately, experiencing three times more diagnoses and four times more deaths from cervical cancer compared to the non-Indigenous population.

Data from 2024 shows that screening participation is also lower among racialized groups (49-63%), immigrants (65%), and those with disabilities (58%). HPV self-screening is seen as a transformative tool to address these inequities. It offers a solution to barriers such as a lack of trust in the healthcare system, experiences of trauma, privacy concerns, and the logistical challenges of reaching a clinic in remote or rural areas.

The success of BC's self-screening initiative and the upcoming pilot in the Northwest Territories demonstrate the power of putting screening tools directly into the hands of the people who need them most. Dr. Earle notes that such programs are "key to advancing health equity and reconciliation, which are priorities of the Action Plan." By providing culturally safer and more accessible options, Canada can begin to close the deadly gaps in care that have persisted for generations.

A Race Against a Preventable Disease

With the 2040 deadline looming, the recent statistics serve as a stark wake-up call. The plateau in progress and the unprecedented rise in cervical cancer incidence put Canada at risk of falling behind other nations, like Australia, that are on a faster trajectory toward elimination. The country's fragmented healthcare system, coupled with laboratory and workforce shortages, presents ongoing hurdles to the swift, nationwide implementation of both vaccination catch-up programs and modern screening technologies.

The message from the Canadian Partnership Against Cancer is one of cautious optimism mixed with urgent warning. The tools and the strategy to make cervical cancer a disease of the past exist. However, achieving this historic public health goal will require an unwavering and unified commitment from all levels of government and health systems to accelerate action now. The coming years will determine whether the 2040 vision becomes a public health triumph or a missed opportunity to save hundreds of lives annually.